Amlodipine Besylate Tablet
Product Images NDC 71610-620

5 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 71610-620). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural-formula-of-amlodipine-besylate (Structural Formula)

Structural-formula-of-amlodipine-besylate (Structural Formula)
Chemical structure diagram of amlodipine besylate, illustrating the molecular arrangement of atoms including chlorine, oxygen, nitrogen, methyl groups, and the besylate moiety attached to the amlodipine core.*
FDA Label Image

Kaplan-meier-analysis (Kaplan Meier Analysis)

Kaplan-meier-analysis (Kaplan Meier Analysis)
A line graph comparing event rates over 24 months between two groups labeled Amlodipine and Placebo. The vertical axis shows event rate, while the horizontal axis shows time in months. The graph includes statistical data with a p-value of 0.003 and a hazard ratio of 0.691 (95% CI 0.54 to 0.88). The number of subjects at risk is shown below the X axis at various time points.*
FDA Label Image

Effects-on-primary-endpoint-of-amlodipine (Effects On Primary Endpoint Of Amlodipine)

Effects-on-primary-endpoint-of-amlodipine (Effects On Primary Endpoint Of Amlodipine)
A forest plot chart depicting hazard ratios with 95% confidence intervals for various patient subgroups comparing Amlodipine versus placebo. Subgroups include overall patients, age groups (<85 and ≥85), gender (male and female), baseline sitting systolic blood pressure, baseline vessel disease status, presence of vessels with stenosis, and PCI-stent status. The x-axis shows hazard ratios from 0 to 2, indicating favor towards Amlodipine or placebo.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

71610-0620-80 (71610 0620 80)

71610-0620-80 (71610 0620 80)
Packaging label for Amlodipine Besylate USP 10 mg tablets, containing 180 tablets. The label includes storage instructions to keep between 20-25 degrees Celsius and to store in a USP controlled room temperature environment. It is manufactured by Epic Pharma, LLC and repackaged by Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. The product is for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.